WIRB-Copernicus Group (WCG), a provider of regulatory and ethical review services for clinical research, announced today it has acquired New England Independent Review Board (IRB).

The Boston-based New England IRB expands WCG’s presence in the northeastern biopharma clinical research hub and further increases its expertise in all phases of drug, medical device and behavioral research.

Publication: Outsourcing-Pharma.com

To read this article, click here.

Print Friendly